Tessmer James F
Insider CIK 1434095 · LXRX VP, Finance & Accounting
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-03-15 | 2021-03-16 | 12,000 | — | $0 | 50,980 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-03-15 | 2021-03-16 | 12,000 | $3.31 | $39.7K | 83,766 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | S Sale | 2021-03-15 | 2021-03-16 | 12,000 | $6.93 | $83.2K | 71,766 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | S Sale | 2021-03-15 | 2021-03-16 | 10,912 | $6.90 | $75.3K | 71,766 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 13,997 | — | $0 | 27,993 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 1,270 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 8,836 | — | $0 | 8,837 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 4,213 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 1,270 | — | $0 | 66,397 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 8,836 | — | $0 | 79,446 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 13,997 | — | $0 | 93,443 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 10,765 | $7.19 | $77.4K | 82,678 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 4,213 | — | $0 | 70,610 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 16,230 | — | $0 | 16,230 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 24,340 | — | $0 | 24,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 3,997 | $1.96 | $7.8K | 65,127 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 13,262 | — | $0 | 69,124 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 1,270 | — | $0 | 1,270 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 8,837 | — | $0 | 17,673 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,075 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 4,214 | — | $0 | 4,213 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 3,902 | $2.77 | $10.8K | 55,862 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 8,837 | — | $0 | 59,764 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 4,214 | — | $0 | 50,927 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 1,270 | — | $0 | 46,713 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,075 | — | $0 | 45,443 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 41,990 | — | $0 | 41,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 62,980 | — | $0 | 62,980 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-02 | 2019-08-02 | 10,000 | $1.14 | $11.4K | 43,368 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,668 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 4,213 | — | $0 | 8,427 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 1,270 | — | $0 | 2,540 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,075 | — | $0 | 2,075 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,075 | — | $0 | 30,386 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 1,270 | — | $0 | 31,656 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 4,213 | — | $0 | 35,869 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-01 | 2,501 | $5.51 | $13.8K | 33,368 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,668 | — | $0 | 28,311 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 26,510 | — | $0 | 26,510 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 39,770 | — | $0 | 39,770 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-06-08 | 2018-06-12 | 10,000 | — | $0 | 11,428 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-06-08 | 2018-06-12 | 10,000 | $10.15 | $101.5K | 35,643 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | S Sale | 2018-06-08 | 2018-06-12 | 10,000 | $12.91 | $129.1K | 25,643 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,075 | — | $0 | 4,150 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,668 | — | $0 | 2,668 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 1,340 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 1,270 | — | $0 | 3,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 1,805 | $8.53 | $15.4K | 25,643 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 1,340 | — | $0 | 21,435 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,668 | — | $0 | 24,103 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,075 | — | $0 | 26,178 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 1,270 | — | $0 | 27,448 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 12,640 | — | $0 | 12,640 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 18,970 | — | $0 | 18,970 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,075 | — | $0 | 6,225 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 857 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,668 | — | $0 | 5,336 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 1,339 | — | $0 | 1,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,075 | — | $0 | 22,885 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 1,339 | — | $0 | 18,142 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2017-02-28 | 2017-03-01 | 2,790 | $16.45 | $45.9K | 20,095 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,668 | — | $0 | 20,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 857 | — | $0 | 16,803 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 5,080 | — | $0 | 5,080 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 11,850 | — | $0 | 11,850 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-06-06 | 2016-06-08 | 1,500 | — | $0 | 17,399 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | S Sale | 2016-06-06 | 2016-06-08 | 1,500 | $15.00 | $22.5K | 15,946 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-06-06 | 2016-06-08 | 1,500 | $6.23 | $9.3K | 17,446 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-05-23 | 2016-05-23 | 6,000 | — | $0 | 18,899 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-05-23 | 2016-05-23 | 6,000 | $6.23 | $37.4K | 21,946 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | S Sale | 2016-05-23 | 2016-05-23 | 6,000 | $13.00 | $78.0K | 15,946 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,667 | — | $0 | 8,004 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 965 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 857 | — | $0 | 857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 1,339 | — | $0 | 2,679 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 965 | — | $0 | 12,709 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,667 | — | $0 | 17,572 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 1,339 | — | $0 | 14,905 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2016-02-29 | 2016-03-02 | 1,626 | $9.07 | $14.7K | 15,946 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 857 | — | $0 | 13,566 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 8,300 | — | $0 | 8,300 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 19,360 | — | $0 | 19,360 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 9,375 | — | $0 | 28,125 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 7,500 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 6,750 | — | $0 | 6,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 6,000 | — | $0 | 12,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 6,750 | — | $0 | 75,891 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 7,500 | — | $0 | 69,141 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 6,000 | — | $0 | 81,891 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 9,375 | — | $0 | 91,266 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2015-03-02 | 2015-03-03 | 9,041 | $0.94 | $8.5K | 82,225 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 174,300 | — | $0 | 174,300 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 74,700 | — | $0 | 74,700 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 6,000 | — | $0 | 18,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 6,750 | — | $0 | 13,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 6,750 | — | $0 | 62,253 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 6,000 | — | $0 | 68,253 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 7,500 | — | $0 | 55,503 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 6,612 | $1.92 | $12.7K | 61,641 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 87,500 | — | $0 | 87,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 7,500 | — | $0 | 15,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 6,750 | — | $0 | 20,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 3,807 | $1.98 | $7.5K | 48,003 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 7,500 | — | $0 | 45,060 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 6,750 | — | $0 | 51,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 56,000 | — | $0 | 56,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-01-31 | 2013-02-04 | 13,200 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-01-31 | 2013-02-04 | 4,310 | $2.11 | $9.1K | 37,560 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-01-31 | 2013-02-04 | 13,200 | — | $0 | 41,870 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2012-02-28 | 2012-03-01 | 7,500 | — | $0 | 22,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2012-02-28 | 2012-03-01 | 7,500 | — | $0 | 30,969 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2012-02-28 | 2012-03-01 | 2,299 | $1.78 | $4.1K | 28,670 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 61,000 | — | $0 | 61,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 27,000 | — | $0 | 27,000 | SEC↗ |